RayStation 6 Proton QA Module Recall for Potential Dosage Errors
RaySearch Laboratories is recalling RayStation 6 software due to a defect in the proton QA module that may result in incorrect patient dosage calculations.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a risk of incorrect dosage to patients, which aligns with the rubric for Severe severity (FDA Class II with potential for significant injury).
Plain-English summary
RaySearch Laboratories AB is recalling 117 units of RayStation 6 software, specifically versions 6.0.0.24, 6.1.0.26, 6.1.1.2, and 6.2.0.7. The recall involves the proton QA preparation module, including Service Packs 1 and 2. The software is used for treatment planning and analysis of radiation therapy.
The recall was initiated because if the snout position or gap is modified in the QA module, the dose may be computed for a different setup than what is used for QA measurements. This defect could result in an incorrect dosage being provided to a patient. The affected units were distributed nationwide in the United States, including in Florida, Washington, Arizona, Tennessee, Maryland, Texas, Michigan, and Washington D.C.
The U.S. Food and Drug Administration has classified this as a Class II recall. No specific instructions for consumers are provided in the source text, but the software is intended for use by medical professionals after review and approval.
The recalled product
- Product
- RayStation Product Usage: is a software system designed for treatment planning and analysis of radiation therapy. The treatment plans provide treatment unit set-up parameters and estimates of dose distributions expected during the proposed treatment, and may be used to admin
- Manufacturer
- RAYSEARCH LABORATORIES AB
- Affected units
- 117
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- 6.0.0.24
- 6.1.0.26
- 6.1.1.2 or 6.2.0.7
Distribution
Related recalls
Same manufacturer · RAYSEARCH LABORATORIES AB
See all →- HighRayCare 2024A SP1 Oncology Information System Software Recall
FDA (Devices) · 2026-07-08
- HighRayCare 2024A SP4 Oncology System Beam Set Delivery Note Data Loss
FDA (Devices) · 2026-07-08
- HighRayStation 2024A treatment planning recalled over dose that fails to invalidate
FDA (Devices) · 2026-01-28
- HighRayStation 2023B and 2024A recalled over dose that fails to invalidate
FDA (Devices) · 2026-01-28
- HighRayStation v2025 treatment planning recalled over dose that fails to invalidate
FDA (Devices) · 2026-01-28
Same hazard · incorrect dosage
See all →- ModerateCephalexin oral suspension recalled for incorrect label dosage amount
FDA (Drugs) · 2024-06-12
- HighSynthroid Levothyroxine Tablets Recalled for Incorrect Barcode Labeling
FDA (Drugs) · 2023-11-15
- HighDigoxin Tablets Recalled Due to Reversed Dosage Labeling
FDA (Drugs) · 2023-09-13
- HighLupin Recalls Lisinopril 5 mg Tablets Due to Product Mix-Up
FDA (Drugs) · 2020-06-17
- HighCareFusion Alaris Syringe Module Software Error Recall
FDA (Devices) · 2020-03-11